Qin Hua, Zhao Andong, Fu Xiaobing
Tianjin Medical University, Tianjin, 300070, China.
Key Laboratory of Wound Repair and Regeneration of PLA, The First Hospital Affiliated to the PLA General Hospital, 51 Fu Cheng Road, Haidian District, Beijing, 100048, China.
Cell Mol Life Sci. 2017 Oct;74(19):3553-3575. doi: 10.1007/s00018-017-2586-x. Epub 2017 Jul 11.
Pluripotency reprogramming and transdifferentiation induced by transcription factors can generate induced pluripotent stem cells, adult stem cells or specialized cells. However, the induction efficiency and the reintroduction of exogenous genes limit their translation into clinical applications. Small molecules that target signaling pathways, epigenetic modifications, or metabolic processes can regulate cell development, cell fate, and function. In the recent decade, small molecules have been widely used in reprogramming and transdifferentiation fields, which can promote the induction efficiency, replace exogenous genes, or even induce cell fate conversion alone. Small molecules are expected as novel approaches to generate new cells from somatic cells in vitro and in vivo. Here, we will discuss the recent progress, new insights, and future challenges about the use of small molecules in cell fate conversion.
转录因子诱导的多能性重编程和转分化可产生诱导多能干细胞、成体干细胞或特化细胞。然而,诱导效率和外源基因的重新引入限制了它们在临床应用中的转化。靶向信号通路、表观遗传修饰或代谢过程的小分子可调节细胞发育、细胞命运和功能。在最近十年中,小分子已广泛应用于重编程和转分化领域,其可提高诱导效率、替代外源基因,甚至单独诱导细胞命运转变。小分子有望成为在体外和体内从体细胞生成新细胞的新方法。在此,我们将讨论小分子在细胞命运转变应用方面的最新进展、新见解和未来挑战。